|
End-of-day quote
TEL AVIV STOCK EXCHANGE
2026-09-14
|
5-day change | 1st Jan Change | ||
| 1,593.00 ILa | -0.06% |
|
-4.55% | - |
| 07-14 | Rafa Laboratories Ltd. has completed an IPO in the amount of ILS 549.8718 million. | CI |
| 07-08 | Rafa Laboratories Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| RAFA | End-of-day quote | |
TEL AVIV STOCK EXCHANGE
| RAFA | Delayed |
| 1 day | -0.06% | ||
| 1 week | -4.55% | ||
| Current month | -1.91% | ||
| 1 month | +8.44% |
| 1 week | 1,571 |  | 1,735 |
| 1 month | 1,401 | | 1,735 |
| Current year | 1,401 | | 1,803 |
| 1 year | 1,401 | | 1,803 |
| 3 years | 1,401 | | 1,803 |
| 5 years | 1,401 | | 1,803 |
| 10 years | 1,401 | | 1,803 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ido Leshem
CEO | Chief Executive Officer | 50 | 2023-12-31 |
Gabi Hazan
COO | Chief Operating Officer | 57 | 2006-12-31 |
Yael Paula Tomer
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gillon Beck
BRD | Director/Board Member | 64 | 2020-12-30 |
Abraham Dadon
BRD | Director/Board Member | 70 | 2026-05-26 |
Amir Levin
BRD | Director/Board Member | 60 | 2007-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | -4.55% | - | - | 515M | |
| +2.02% | -0.96% | +50.69% | +90.07% | 994B | |
| +0.28% | -3.24% | +49.57% | +62.40% | 640B | |
| +1.81% | +2.07% | +19.89% | +73.17% | 454B | |
| +5.00% | +1.23% | +36.64% | +40.84% | 337B | |
| +1.68% | -12.09% | +15.25% | +26.83% | 261B | |
| +3.81% | +1.23% | +3.05% | +14.86% | 246B | |
| +1.10% | -12.75% | +38.03% | +48.31% | 204B | |
| +1.43% | -6.19% | -19.49% | -58.38% | 190B | |
| +1.87% | -3.04% | +27.81% | +89.38% | 178B | |
| Average | +1.67% | -5.81% | +24.60% | +43.05% | 350.53B | |
| Weighted average by Cap. | +1.33% | -4.42% | +33.46% | +57.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 420M 42.01B 138M 120M 113M 102M 192M 13.2B 194M 1.35B 518M 6.72B 519M 507M 21.32B | 418M 41.84B 138M 119M 112M 102M 191M 13.15B 193M 1.34B 516M 6.69B 517M 505M 21.23B |
| Net income | 99.43M 9.94B 32.7M 28.31M 26.72M 24.19M 45.41M 3.12B 45.8M 319M 123M 1.59B 123M 120M 5.05B | 100M 10.03B 33M 28.57M 26.96M 24.41M 45.82M 3.15B 46.22M 321M 124M 1.6B 124M 121M 5.09B |
| Net Debt | - | - |
Employees
257
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | ILA 1,593.00 | -0.06% | 390,751 |
| 26-09-10 | ILA 1,594.00 | +0.95% | 11,986 |
| 26-09-09 | ILA 1,579.00 | -5.90% | 385,717 |
| 26-09-08 | ILA 1,678.00 | -1.29% | 10,504 |
- Stock Market
- Stocks
- RAFA Stock
Select your edition
All financial news and data tailored to specific country editions
